Safeway jumps on $4 generic bandwagon

Just two years ago, Wal-Mart started its program to sell a select list of generic prescription drugs for just $4 as part of its entry into the healthcare and pharmaceutical spaces. It looks like the retail giant kicked off a major trend.

Now Safeway plans to follow suit and be the first full grocery retailer to hop on the $4 prescription bandwagon. Target also copied Wal-Mart's assertive sales strategy, and now consumers have access to literally hundreds of generic drugs at the $4 price point, including medications for thyroid disease and hypertension, as well as antibiotics. It's a trend that's sure to please price-conscious consumers, but give headaches to drugmakers already hurt generic competition.

- read the here's the Washington Post article
- get more on this story at MSNBC

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.